Teva wins battle with Pfizer over Viagra patent

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Teva wins battle with Pfizer over Viagra patent

viagra2-1-45.jpg

The Supreme Court of Canada on Thursday said that Pfizer’s blockbuster patent on the erectile dysfunction drug Viagra is invalid, reversing a Federal Court ruling that blocked Teva's application to market generic Viagra under the Patented Medicines (Notice of Compliance) Act (PM[NOC])

The decision is interesting in that the Supreme Court took the step of finding the patent invalid, rather than simply allowing the Canadian Minister of Health to grant the notice of compliance, said Sean Jackson of IP Osgoode.

viagra2-1-250.jpg

It has also clarified the Canadian disclosure requirement. “Sufficiency of disclosure lies at the very heart of the patent system, so adequate disclosure in the specification is a precondition for the granting of a patent,” said the judgment. In this respect, the Court found Pfizer’s patent lacking. The panel explained: “Although the patent includes the statement that ‘one of the especially preferred compounds induces penile erection in impotent males’, the patent application does not disclose that the compound that works is sildenafil, that it is found in Claim 7, or that the remaining compounds had not been found to be effective in treating ED.”

Pfizer’s patent was due to expire in 2014. Teva said its generic version of the drug will “result in millions in savings to consumers”.

more from across site and SHARED ros bottom lb

More from across our site

Attorneys explain why there are early signs that the US Supreme Court could rule in favour of ISP Cox in a copyright dispute
A swathe of UPC-related hires suggests firms are taking the forum seriously, as questions over the transitional stage begin
A win for Nintendo in China and King & Spalding hiring a prominent patent litigator were also among the top talking points
Rebecca Newman at Addleshaw Goddard, who live-reported on the seminal dispute, unpicks the trials and tribulations of the case and considers its impact
Attorneys predict how Lululemon’s trade dress and design patent suit against Costco could play out
Lawyers at Linklaters analyse some of the key UPC trends so far, and look ahead to life beyond the transition period
David Rodrigues, who previously worked at an IP boutique, said he may become more involved in transactional work at his new firm
Indian smartphone maker Lava must pay $2.3 million as a security deposit for past sales, as its dispute with Dolby over audio coding SEPs plays out
Powell Gilbert’s opening in Düsseldorf, complete with a new partner hire, continues this summer’s trend of UPC-related lateral movement
IP leaders at Brandsmiths and Bird & Bird, who were on opposing sides at the UK Supreme Court in Iconix v Dream Pairs, unpick the landmark case and its ramifications
Gift this article